International Regulatory, special projects, Team lead @ Pharmaselect
Associate Director Regulatory Affairs, Recombinant Hematology and Rare Metabolic (neurological) @ Baxalta Innovations GmbH (since 8 Jan 2019 part Takeda, previously part of Shire
Regulatory Affairs Manager, Oncology and biosimilars @ Baxalta
Michaela Flego-Kamensek, based in Austria, is currently a Global Program Regulatory Director at Sandoz, bringing experience from previous roles at Pharmaselect, Baxalta Innovations GmbH (since 8 Jan 2019 part Takeda, previously part of Shire, Baxalta and Baxter Innovations. Michaela Flego-Kamensek holds a University of Vienna. Michaela Flego-Kamensek has 1 email on RocketReach.